Which second-line treatment regimen should be used following relapse of platinum-sensitive ovarian cancer?

被引：0
|
作者：
Pecorelli, Sergio
Odicino, Franco
机构：
[1] Univ Brescia, Dept Obstet & Gynecol, Div Gynecol Oncol, I-25123 Brescia, Italy
[2] Univ Brescia, Dept Obstet & Gynecol, Brescia, Italy
来源：
NATURE CLINICAL PRACTICE ONCOLOGY | 2007年 / 4卷 / 06期
关键词：
carboplatin; gemcitabine; ovarian cancer; progression-free survival; response rate;
D O I：
10.1038/ncponc0795
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：340 / 341
页数：2
相关论文
共 50 条
  • [21] Combination carboplatin and pemetrexed for the treatment of platinum-sensitive recurrent ovarian cancer
    Horowitz, N. S.
    Penson, R. T.
    Campos, S. M.
    Lee, J.
    Kendall, D. L.
    Krasner, C. N.
    Berlin, S. T.
    Roche, M.
    Duska, L. R.
    Matulonis, U. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [22] Olaparib as maintenance treatment for patients with platinum-sensitive relapsed ovarian cancer
    Ledermann, Jonathan A.
    Pujade-Lauraine, Eric
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2019, 11
  • [23] COMPARATIVE EFFECTIVENESS OF PLATINUM PLUS PACLITAXEL, PLATINUM PLUS LIPOSOMAL DOXORUBICIN, TOPOTECAN, AND LIPOSOMAL DOXORUBICIN FOR SECOND-LINE CHEMOTHERAPY AMONG PLATINUM-SENSITIVE PATIENTS WITH RECURRENT ADVANCED OVARIAN CANCER IN TAIWAN
    Huang, H.
    Tang, C.
    Cheng, W.
    You, S.
    Chiang, C.
    Chen, Y.
    VALUE IN HEALTH, 2017, 20 (05) : A92 - A92
  • [24] Niraparib also used as Maintenance Therapy for newly diagnosed Platinum-sensitive Ovarian Cancer
    Weiss, Steffi
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 (1-2) : 67 - 67
  • [25] Outcomes and patterns of secondary relapse in platinum-sensitive ovarian cancer: Implications for tertiary cytoreductive surgery
    Tang, J.
    Liu, D. L.
    Shu, S.
    Tian, W. J.
    Liu, Y.
    Zang, R. Y.
    EJSO, 2013, 39 (07): : 786 - 791
  • [26] Trabectedin therapy as an emerging treatment strategy for recurrent platinum-sensitive ovarian cancer
    Antonio Lopez-Guerrero, Jose
    Romero, Ignacio
    Poveda, Andres
    CHINESE JOURNAL OF CANCER, 2015, 34 (01) : 41 - 49
  • [27] Treatment strategy for patients with platinum-sensitive ovarian cancer using PARP inhibitors
    Matsumoto, Koji
    ANNALS OF ONCOLOGY, 2019, 30
  • [28] Trabectedin therapy as an emerging treatment strategy for recurrent platinum-sensitive ovarian cancer
    Jos Antonio LpezGuerrero
    Ignacio Romero
    Andrs Poveda
    Chinese Journal of Cancer, 2015, 34 (01) : 41 - 49
  • [29] Emerging treatment strategies in recurrent platinum-sensitive ovarian cancer: Focus on trabectedin
    Poveda, Andres
    Ray-Coquard, Isabelle
    Romero, Ignacio
    Antonio Lopez-Guerrero, Jose
    Colombo, Nicoletta
    CANCER TREATMENT REVIEWS, 2014, 40 (03) : 366 - 375
  • [30] RT in platinum-sensitive oligometastatic ovarian cancer: an alternative to delay systemic treatment
    Corrao, G.
    Lazzari, R.
    Durante, S.
    Pierini, V.
    Repetti, I.
    Lorubbio, C.
    Comi, S.
    Multinu, F.
    Cattani, F.
    Maggioni, A.
    Colombo, N.
    Jereczek-Fossa, B. A.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S681 - S682
12345